Literature DB >> 27693212

PRDM14 inhibits 293T cell proliferation by influencing the G1/S phase transition.

Yanan Lu1, Zhiyi Wan2, Xueqing Zhang3, Xiaorong Zhong4, Lei Rui5, Zandong Li6.   

Abstract

PRDM14 (PRDI-BF1 and RIZ domain-containing 14), a transcription factor, plays important roles in primordial germ cell specification and embryonic stem cell pluripotency, and supports the maintenance of self-renewal by promoting the expression of stem cell markers while also repressing the expression of differentiation factors. As a proto-oncogene, the ectopic expression of PRDM14 can enhance breast cell growth and reduce breast cell sensitivity to chemotherapeutic drugs. Conversely, knockdown of PRDM14 expression induces apoptosis in breast cancer cells and restores their sensitivity to chemotherapeutic drugs. Here, we sought to identify the role of PRDM14 in 293T cells. PRDM14-infected 293T cells exhibited an abnormal morphology, and we found that ectopic expression of PRDM14 inhibits colony formation, cell proliferation and metastasis. In addition, our data indicated that PRDM14 influences the G1/S phase transition of 293T cells by inducing the expression of cell cycle regulators. In conclusion, these results showed that PRDM14 inhibits 293T cell proliferation by influencing the G1/S phase transition and impacts cell migration by regulating the level of MMP/TIMP expression, thus mediating extracellular matrix degradation.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell cycle; Cell proliferation; Migration; PRDM14

Mesh:

Substances:

Year:  2016        PMID: 27693212     DOI: 10.1016/j.gene.2016.09.039

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  6 in total

1.  PRDM14 mediates chemosensitivity and glycolysis in drug‑resistant A549/cisplatin cells and their progenitor A549 human lung adenocarcinoma cells.

Authors:  Saifei He; Xiaokun Ma; Ni Zheng; Guoyu Wang; Menghan Wang; Wei Xia; Donghai Yu
Journal:  Mol Med Rep       Date:  2020-12-23       Impact factor: 2.952

2.  Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on risk.

Authors:  Lavanya Lokhande; Venera Kuci Emruli; Arne Kolstad; Martin Hutchings; Riikka Räty; Mats Jerkeman; Sara Ek
Journal:  BMC Cancer       Date:  2020-12-07       Impact factor: 4.430

3.  Large chromosomal deletions and impaired homologous recombination repairing in HEK293T cells exposed to polychlorinated biphenyl 153.

Authors:  Jiaci Li; Yaqing Jing; Yi Liu; Yawei Ru; Mingyan Ju; Yuxia Zhao; Guang Li
Journal:  PeerJ       Date:  2021-07-28       Impact factor: 2.984

4.  Glucose insult elicits hyperactivation of cancer stem cells through miR-424-cdc42-prdm14 signalling axis.

Authors:  Sushmita Bose Nandy; Alexis Orozco; Rebecca Lopez-Valdez; Rene Roberts; Ramadevi Subramani; Arunkumar Arumugam; Alok Kumar Dwivedi; Viktoria Stewart; Gautham Prabhakar; Stephanie Jones; Rajkumar Lakshmanaswamy
Journal:  Br J Cancer       Date:  2017-10-12       Impact factor: 7.640

5.  Improving knowledge on the activation of bone marrow fibroblasts in MGUS and MM disease through the automatic extraction of genes via a nonnegative matrix factorization approach on gene expression profiles.

Authors:  Angelina Boccarelli; Flavia Esposito; Mauro Coluccia; Maria Antonia Frassanito; Angelo Vacca; Nicoletta Del Buono
Journal:  J Transl Med       Date:  2018-08-03       Impact factor: 5.531

Review 6.  Multifaceted Role of PRDM Proteins in Human Cancer.

Authors:  Amelia Casamassimi; Monica Rienzo; Erika Di Zazzo; Anna Sorrentino; Donatella Fiore; Maria Chiara Proto; Bruno Moncharmont; Patrizia Gazzerro; Maurizio Bifulco; Ciro Abbondanza
Journal:  Int J Mol Sci       Date:  2020-04-10       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.